Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Martinez-Laperche, C
- Kwon, M
- Franco-Villegas, AC
- Chillon, MC
- Castro, N
- Rodriguez-Medina, C
- Hermosin, L
- Prieto-Conde, MI
- Gomez-Casares, M
- Ayala, R
- Martinez-Lopez, J
- Gonzalez-Diaz, M
- Diez-Martin, JL
- Buno, I
- Cooperative Group for Molecular Biology in Haematology (GBMH)
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0007-1048, 1365-2141
- Tipo:
- Letter
- Páginas:
- 542-546
- DOI:
- 10.1111/bjh.14635
- PubMed:
- 28369773
- Factor de Impacto:
- 2,089 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
BRITISH JOURNAL OF HAEMATOLOGY WILEY
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- acute myeloid leukaemia; Wilms Tumor 1; chemotherapy; minimal residual disease; stem cell transplantation
Campos de Estudio
Cita
Martinez C,Kwon M,Franco AC,Chillon MC,Castro N,Anguita E,Dolz S,Rodriguez C,Hermosin L,Bellon JM,Prieto MI,Barragan E,Gomez M,Ayala R,Martinez J,Gonzalez M,Diez JL,Buno I,Cooperative Group for Molecular Biology in Haematology (GBMH). Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology. Br. J. Haematol. 2018. 181(4):p. 542-546. IF:5,206. (1).
Portal de investigación